ESG risk score 26.77
Environmental score 6.29
Social score 13.64
Governance score 6.85
ESG risk category Medium
Negligible Low Med High Severe
0-10 10-20 20-30 30-40 40+
Penumbra Inc.
000.00
0.00 / 0.00%
00:00:00
52 week range
0000.00 000.00
Symbol PEN:xnys
Currency USD
New York Stock Exchange
Open Closed
15 minutes delayed
Data provided by 
This information is not currently available for this instrument. Refresh the page or try again later.
Want to start investing?
Trade stocks with a broker trusted by over 1.5 million clients. Investing involves risk. You may lose some or all of your investment.
Chart
This information is not currently available for this instrument. Refresh the page or try again later.
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
This information is not currently available for this instrument. Refresh the page or try again later.
Returns
Year to date (YTD) 6.1%
1 year 25.77%
3 years 20.32%
Data provided by 
Key stats
Price/earnings (LTM) 72.93
Dividend yield (LTM) -
EPS (LTM) 4.52
Volatility (30 days) 9.22%
Data provided by
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Data provided by 
/ 
/ Financials
Q1 Q2 Q3 Q4
Income statement
Revenue XXXXXXX XXXXXXX XXXXXXX XXXXXXX
EBITDA XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Net income XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Balance sheet
Total assets XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Total debt XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Ratios
Price/sales XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Earnings per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Dividend per share XXXXXXX XXXXXXX XXXXXXX XXXXXXX
Return on equity XXXXXXX XXXXXXX XXXXXXX XXXXXXX
About Penumbra Inc.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
Sector Healthcare
Industry -
Market cap 13bn
Data provided by /
/ Frequently asked questions
To buy Penumbra Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Penumbra Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Penumbra Inc. is PEN:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Penumbra Inc. has its primary listing on New York Stock Exchange. You can trade Penumbra Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Penumbra Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Penumbra Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Penumbra Inc. or others.